Correlation Between Tanvex BioPharma and PharmaEngine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and PharmaEngine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and PharmaEngine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tanvex BioPharma and PharmaEngine, you can compare the effects of market volatilities on Tanvex BioPharma and PharmaEngine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of PharmaEngine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and PharmaEngine.

Diversification Opportunities for Tanvex BioPharma and PharmaEngine

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Tanvex and PharmaEngine is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and PharmaEngine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmaEngine and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with PharmaEngine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmaEngine has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and PharmaEngine go up and down completely randomly.

Pair Corralation between Tanvex BioPharma and PharmaEngine

Assuming the 90 days trading horizon Tanvex BioPharma is expected to generate 0.82 times more return on investment than PharmaEngine. However, Tanvex BioPharma is 1.23 times less risky than PharmaEngine. It trades about 0.26 of its potential returns per unit of risk. PharmaEngine is currently generating about 0.16 per unit of risk. If you would invest  6,110  in Tanvex BioPharma on October 24, 2024 and sell it today you would earn a total of  820.00  from holding Tanvex BioPharma or generate 13.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tanvex BioPharma  vs.  PharmaEngine

 Performance 
       Timeline  
Tanvex BioPharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Tanvex BioPharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Tanvex BioPharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
PharmaEngine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days PharmaEngine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, PharmaEngine is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Tanvex BioPharma and PharmaEngine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tanvex BioPharma and PharmaEngine

The main advantage of trading using opposite Tanvex BioPharma and PharmaEngine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, PharmaEngine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will offset losses from the drop in PharmaEngine's long position.
The idea behind Tanvex BioPharma and PharmaEngine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world